Current Research Information SysTem In Norway
 
 

 Norsk versjon


 
Mainpage
Research results/NVI
Researchers
Projects
Research units
Log in
About Cristin
 
 
   
Back to search     Short format     Full format    
Export to


Showing results 1-25 of 25

2016
1 Jørgensen, Silje Fjellgård; Macpherson, Magnhild E; Bjøro, Kristian; Karlsen, Tom Hemming; Reims, Henrik Mikael; Grzyb, Krzysztof; Fosby, Bjarte; Fevang, Børre; Aukrust, Pål; Nordøy, Ingvild.
Liver transplantation in patients with primary antibody deficiency. Journal of Allergy and Clinical Immunology 2016 p. -
OUS UiO Untitled
 
2015
2 Dalgard, Olav; Martinot-Peignoux, Michelle; Verbaan, Hans; Bjøro, Kristian; Ring-Larsen, Helmer; Marcellin, Patrick.
The usefulness of defining rapid virological response by a very sensitive assay (TMA) during treatment of HCV genotype 2/3 infection. PLOS ONE 2015 ;Volume 10.(8) p. -
AHUS OUS UiO Untitled
 
3 Fosby, Bjarte; Melum, Espen; Bjøro, Kristian; Bennet, William; Rasmussen, Allan; Andersen, Ina Riise; Castedal, Maria; Olausson, Michael; Wibeck, Christina; Gotlieb, Mette; Gjertsen, Henrik; Toivonen, Leena; Foss, Stein; Mäkisalo, Heikki; Nordin, Arno; Sanengen, Truls; Bergquist, Annika; Larsson, Marie E.; Söderdahl, Gunnar; Nowak, Greg; Boberg, Kirsten Muri; Isoniemi, Helena; Keiding, Susanne; Foss, Aksel; Line, Pål Dag; Friman, Styrbjörn; Schrumpf, Erik; Ericzon, Bo-Göran; Höckerstedt, Krister; Karlsen, Tom Hemming.
Liver transplantation in the Nordic countries-An intention to treat and post-transplant analysis from the Nordic Liver Transplant Registry 1982-2013. Scandinavian Journal of Gastroenterology 2015 ;Volume 50.(6) p. 797-808
OUS UiO Untitled
 
2014
4 Eskesen, Arne N; Bjøro, Kristian; Aandahl, Einar Martin; Line, Pål Dag; Melum, Espen.
Low use of surveillance and early diagnosis of hepatocellular carcinoma in Norway-A population-based cohort study. Cancer Epidemiology 2014 ;Volume 38.(6) p. 741-747
AHUS OUS UiO Untitled
 
2012
5 Eskesen, Arne N; Melum, Espen; Moghaddam, Amir; Bjøro, Kristian; Verbaan, Hans; Ring-Larsen, Helmer; Dalgard, Olav.
Genetic variants at the ITPA locus protect against ribavirin-induced hemolytic anemia and dose reduction in an HCV G2/G3 cohort. European Journal of Gastroenterology and Hepathology 2012 ;Volume 24.(8) p. 890-896
AHUS OUS Untitled
 
2011
6 Moghaddam, Amir; Melum, Espen; Reinton, Nils; Ring-Larsen, Helmer; Verbaan, Hans; Bjøro, Kristian; Dalgard, Olav.
IL28B Genetic Variation and Treatment Response in Patients with Hepatitis C Virus Genotype 3 Infection. Hepatology 2011 ;Volume 53.(3) p. 746-754
OUS Untitled
 
2010
7 Bjøro, Kristian.
This month in Scandinavian Journal of Gastroenterology. Scandinavian Journal of Gastroenterology 2010 ;Volume 45.(6) p. 643-644
OUS Untitled
 
8 Dahl, Tuva Børresdatter; Haukeland, John Willy; Yndestad, Arne; Ranheim, Trine; Gladhaug, Ivar Prydz; Damås, Jan Kristian; Haaland, Therese Kristina; Løberg, Else Marit; Arntsen, Borghild M; Birkeland, Kåre I.; Bjøro, Kristian; Ulven, Stine Marie; Zbigniew, Konopski; Nebb, Hilde Irene; Aukrust, Pål; Halvorsen, Bente.
Intracellular Nicotinamide Phosphoribosyltransferase Protects against Hepatocyte Apoptosis and Is Down-Regulated in Nonalcoholic Fatty Liver Disease. Journal of Clinical Endocrinology and Metabolism 2010 ;Volume 95.(6) p. 3039-3047
OSLOMET OUS UiO Untitled
 
9 Dalgard, Olav; Bjøro, Kristian; Ring-Larsen, H.; Verbaan, H.
In patients with HCV genotype 2 or 3 infection and RVR 14 weeks treatment is noninferior to 24 weeks. Pooled analysis of two Scandinavian trials. European Journal of Gastroenterology and Hepathology 2010 ;Volume 22.(5) p. 552-556
OUS Untitled
 
10 Dalgard, Olav; Moghaddam, Amir; Verbaan, Hans; Ring-Larsen, Helmer; Bjøro, Kristian; Melum, Espen.
IL28B GENETIC VARIATION AND TREATMENT RESPONSE IN PATIENTS WITH HCV GENOTYPE 3 INFECTION. Hepatology 2010 ;Volume 52.(4) p. 751A-751A
OUS Untitled
 
2009
11 Carvalho, RJ; Verbaan, H; Bjøro, Kristian; Ring-Larsen, H; Dalgard, O.
LOW-TO-MODERATE ALCOHOL CONSUMPTION HAS NO IMPACT ON ANTIVIRAL RESPONSE TO COMBINATION THERAPY IN HCV PATIENTS WITH GENOTYPE 2 OR 3. Hepatology 2009 ;Volume 50.(4) p. 687A-688A
UiO Untitled
 
12 Haukeland, John Willy; Zbigniew, Konopski; Eggesbø, Heidi Beate; von Volkmann, HL; Raschpichler, G; Bjøro, Kristian; Haaland, Therese Kristina; Loberg, EM; Birkeland, Kåre I..
Metformin in patients with non-alcoholic fatty liver disease: A randomized, controlled trial. Scandinavian Journal of Gastroenterology 2009 ;Volume 44.(7) p. 853-860
HAUKELAND OUS UNN Untitled
 
2008
13 Dalgard, Odd Steffen; Bjøro, Kristian; Ring-Larsen, H; Verbaan, H.
Is sustained virological response to HCV treatment associated with a clinical important improvement in vitality?. Journal of Hepatology 2008 ;Volume 48. p. S272-S272
UiO Untitled
 
14 Dalgard, Olav; Verbaan, H; Ring-Larsen, H; Bjøro, Kristian.
IN PATIENTS WITH HCV GENOTYPE 2 OR 3 INFECTION AND RVR 14 WEEKS TREATMENT IS NON-INFERIOR TO 24 WEEKS. POOLED ANALYSIS OF TWO SCANDINAVIAN TRIALS. Hepatology 2008 ;Volume 48.(4) p. 1148A-1148A
UiO Untitled
 
15 Haukeland, John Willy; Zbigniew, Konopski; Loberg, EM; Haaland, Therese Kristina; von Volkmann, HL; Raschpichler, G; Eggesbo, HB; Bjøro, Kristian; Birkeland, K.
A RANDOMIZED, PLACEBO CONTROLLED TRIAL WITH METFORMIN IN PATIENTS WITH NAFLD. Hepatology 2008 ;Volume 48.(4) p. 334A-334A
UiO Untitled
 
16 Schrumpf, Erik; Bjøro, Kristian.
Timing of liver transplantation in PSC. Scandinavian Journal of Gastroenterology 2008 ;Volume 43. p. 31-31
UiO Untitled
 
2006
17 Haukeland, John Willy; Damås, Jan Kristian; Konopski, Zbigniew; Loberg, EM; Haaland, T; Goverud, I; Torjesen, PA; Birkeland, Kåre I.; Bjøro, Kristian; Aukrust, Pål.
Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2. Journal of Hepatology 2006 ;Volume 44.(6) p. 1167-1174
OUS UiO Untitled
 
2005
18 Brandsæter, Bjørn Jardar; Schrumpf, Erik; Bentdal, Øystein H.; Braband, Knut; Smith, Hans-Jørgen; Abildgaard, Andreas; Bjøro, Kristian; Clausen, Ole Petter Fraas.
Recurrent primary sclerosing cholangitis after liver transplantation: a magnetic resonance cholangiography study with analyses of predictive factors. Liver transplantation 2005 ;Volume 11.(11) p. 1361-1369
OUS UiO Untitled
 
19 Haukeland, John Willy; Zbigniew, Konopski; Linnestad, P.; Azimy, S.; Løberg, Else Marit; Haaland, T.; Birkeland, Kåre I.; Bjøro, Kristian.
Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease. Scandinavian Journal of Gastroenterology 2005 ;Volume 40.(12) p. 1469-77
OUS UiO Untitled
 
2004
20 Bjøro, Kristian; Schou, IH; Smeby, Nina Aarhus; Hamilton, G.
A strategy for establishing hospital based Nursing Research in Norway. Vård i Norden 2004 ;Volume 24.(1) p. 42-44
UiO Untitled
 
21 Brandsæter, Bjørn Jardar; Isoniemi, H; Broome, U; Olausson, M; Backman, L; Hansen, B; Schrumpf, Erik; Oksanen, A; Ericzon, BG; Hockerstedt, K; Makisalo, H; Kirkegaard, P; Friman, S; Bjøro, Kristian.
"Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy". Journal of Hepatology 2004 ;Volume 40. p. 815-822
UiO Untitled
 
22 Brandsæter, Bjørn Jardar; Schrumpf, Erik; Clausen, Ole Petter Fraas; Abildgaard, Andreas; Hafsahl, Geir; Bjøro, Kristian.
Recurrent sclerosing cholangitis or ischemic bile duct lesions - a diagnostic challenge?. Liver transplantation 2004 ;Volume 10.(8) p. 1073-1074
UiO Untitled
 
23 Dalgaard, O; Bjøro, Kristian; Block Hellum, K; Myrvang, B; Ritland, S; Skaug, K; Raknerud, N; Bell, H.
Treatment with pegylated interferon and ribavarin in HCV infection with genotype 2 og 3 for 14 weeks: a pilot study. Hepatology 2004 ;Volume 40. p. 1260-1265
UiO Untitled
 
24 Dalgard, O; Bjøro, Kristian; Hellum, K; Myrvang, B; Ritland, S; Skaug, K; Raknerud, N; Bell, H.
Short (14 weeks) treatment with pegylated interferon alpha-2B and ribavirin in patients with hepatitis C genotype 2/3 virus infection and early virological response. Hepatology 2004 ;Volume 40. p. 252A-252A
UiO Untitled
 
1995
25 Rokkones, Erik; Fromm, Sigurd H.; Kareem, Najma B.; Klungland, Helge; Olstad, Ole K.; Høgset, Anders; Iversen, Jan; Bjøro, Kristian; Gautvik, Kaare M..
Human Parathyroid Hormone as a Secretory Peptide in Milk of Transgenic Mice. Journal of Cellular Biochemistry 1995 ;Volume 59. p. 168-176
OUS UiO NMBU Untitled